1. Home
  2. BHVN vs RH Comparison

BHVN vs RH Comparison

Compare BHVN & RH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • RH
  • Stock Information
  • Founded
  • BHVN 2013
  • RH 1979
  • Country
  • BHVN United States
  • RH United States
  • Employees
  • BHVN N/A
  • RH N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • RH Other Specialty Stores
  • Sector
  • BHVN Health Care
  • RH Consumer Discretionary
  • Exchange
  • BHVN Nasdaq
  • RH Nasdaq
  • Market Cap
  • BHVN 5.4B
  • RH 5.8B
  • IPO Year
  • BHVN 2017
  • RH 1998
  • Fundamental
  • Price
  • BHVN $45.17
  • RH $344.87
  • Analyst Decision
  • BHVN Strong Buy
  • RH Buy
  • Analyst Count
  • BHVN 13
  • RH 14
  • Target Price
  • BHVN $63.42
  • RH $331.77
  • AVG Volume (30 Days)
  • BHVN 729.5K
  • RH 575.3K
  • Earning Date
  • BHVN 11-12-2024
  • RH 12-05-2024
  • Dividend Yield
  • BHVN N/A
  • RH N/A
  • EPS Growth
  • BHVN N/A
  • RH N/A
  • EPS
  • BHVN N/A
  • RH 1.74
  • Revenue
  • BHVN N/A
  • RH $3,046,100,000.00
  • Revenue This Year
  • BHVN N/A
  • RH $7.52
  • Revenue Next Year
  • BHVN $179.00
  • RH $11.18
  • P/E Ratio
  • BHVN N/A
  • RH $197.81
  • Revenue Growth
  • BHVN N/A
  • RH N/A
  • 52 Week Low
  • BHVN $26.80
  • RH $212.43
  • 52 Week High
  • BHVN $62.21
  • RH $367.00
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 38.20
  • RH 60.90
  • Support Level
  • BHVN $43.18
  • RH $313.00
  • Resistance Level
  • BHVN $54.53
  • RH $346.03
  • Average True Range (ATR)
  • BHVN 2.57
  • RH 12.29
  • MACD
  • BHVN -0.85
  • RH 0.88
  • Stochastic Oscillator
  • BHVN 16.86
  • RH 97.42

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About RH RH

RH is a luxury furniture and lifestyle retailer operating in the $134 billion domestic furniture and home furnishing industry. The firm offers merchandise across many categories including furniture, lighting, textiles, bath, decor, and children and is growing the presence of its hospitality business with 18 restaurant locations. RH innovates, curates, and integrates products, categories, services, and businesses across channels and brand extensions (RH Modern and Waterworks, for example). RH is fully integrated across channels and is positioned to broaden its addressable market over the next decade by expanding abroad, with its World of RH digital platform (highlighting offerings outside of home furnishings), and with offerings in color, bespoke furniture, architecture, media, and more.

Share on Social Networks: